Legend Biotech CEO’s Small Share Sale Proves Routine Tax Move, Not Market Signal
Legend Biotech CEO’s recent share sale is a routine tax event, not a warning—insiders stay passive while the company focuses on oncology cell‑therapy.
3 minutes to read